EUVIMEDEUVIMED entdecken
Crossref

Safety and Preliminary Efficacy of Personalized Neoantigen-pulsed Dendritic Cell Vaccination in Patients With Solid Tumors: An Interim Analysis

Rishu Takimoto, Takashi Kamigaki, Sachiko Okada, Hiroshi Ibe, Eri Oguma, Aya Ohno, Keiko Naito, Yoichiro Yoshida, Seiji Narimiya, Shigenori Goto

Anticancer Research · 2026-08 · 46 (8) · 4699-4706

DOI: 10.21873/anticanres.18326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.07.2026. Verfasst von Rishu Takimoto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Seta Clinic Tokyo, Tokyo, Japan; takimoto@j-immunother.com. Hauptthemen laut MEDLINE: Dendritic Cells, Antigens, Neoplasm, Cancer Vaccines, Neoplasms.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsAntigens, NeoplasmCancer VaccinesNeoplasmsHumansMaleFemaleMiddle AgedAgedAdultPrecision MedicineVaccinationTreatment Outcome

Stichwörter der Autor:innen

Neoantigencancer immunotherapydendritic cell vaccinationimmune-cell therapy

Substanzen

Antigens, NeoplasmCancer Vaccines

Autor:innen und Institutionen

  • Seta Clinic Tokyo, Tokyo, Japan; takimoto@j-immunother.com.
  • Next-Generation Cell and Immunotherapy, Advanced Research Institute for Health Science, Juntendo University, Tokyo, Japan.
  • LSI Sapporo Clinic, Sapporo, Japan.
  • Seta Clinic Tokyo, Tokyo, Japan.
  • Fukuoka Medical Clinic, Fukuoka, Japan.
  • Dojima Liga Clinic, Osaka, Japan.

Zitieren

APA

Takimoto, R., Kamigaki, T., Okada, S., Ibe, H., Oguma, E., Ohno, A., Naito, K., Yoshida, Y., Narimiya, S., & Goto, S. (2026). Safety and Preliminary Efficacy of Personalized Neoantigen-pulsed Dendritic Cell Vaccination in Patients With Solid Tumors: An Interim Analysis. Anticancer Research, 46(8), 4699-4706. https://doi.org/10.21873/anticanres.18326

Vancouver

Takimoto R, Kamigaki T, Okada S, Ibe H, Oguma E, Ohno A, et al. Safety and Preliminary Efficacy of Personalized Neoantigen-pulsed Dendritic Cell Vaccination in Patients With Solid Tumors: An Interim Analysis. Anticancer Research. 2026;46(8):4699-4706. doi:10.21873/anticanres.18326

BibTeX
@article{Takimoto2026,
  author = {Takimoto, Rishu and Kamigaki, Takashi and Okada, Sachiko and Ibe, Hiroshi and Oguma, Eri and Ohno, Aya and Naito, Keiko and Yoshida, Yoichiro and Narimiya, Seiji and Goto, Shigenori},
  title = {Safety and Preliminary Efficacy of Personalized Neoantigen-pulsed Dendritic Cell Vaccination in Patients With Solid Tumors: An Interim Analysis},
  journal = {Anticancer Research},
  year = {2026},
  volume = {46},
  number = {8},
  pages = {4699--4706},
  doi = {10.21873/anticanres.18326}
}
Kostenlos starten →